Nurix Therapeutics, Inc. (NRIX) NASDAQ
16.37
-1.02(-5.87%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.47B |
| Enterprise Value | 1.27B |
| P/E Ratio | -6.1 |
| PEG Ratio | 0.45 |
| Price/Sales Ratio | 19.77 |
| Price/Book Ratio | 3.75 |
| Enterprise/Revenue | 19.59 |
| Enterprise/EBITDA | -4.87 |
Fiscal Year
| Fiscal Year | November 30, 2025 |
| Most Recent Quarter | February 28, 2026 |
Profitability
| Profit Margin | -4.11 |
| Operating Margin | -4.39 |
Management Effectiveness
| Return On Assets | -0.46 |
| Return On Equity | -0.64 |
Income Statement
| Revenue | 83.98M |
| Revenue/Share | 0.65 |
| Gross Profit | 65.12M |
| EBITDA | -244.84M |
| Net Income | -264.46M |
| Diluted EPS | -3.05 |
Balance Sheet
| Total Cash | 540.73M |
| Total Cash/Share | 4.91 |
| Total Debt | 58.66M |
| Total Debt/Equity | 0.12 |
| Current Ratio | 6.01 |
| Book Value Per Share | 4.37 |
Price History
| 52-Week Change | 34.84 |
| 52-Week High | 22.5 |
| 52-Week Low | 8.2 |
| Moving Average 50 Days | 16.32 |
| Moving Average 200 Days | 14.69 |
Statistics
| Average Volume | 1.13M |
| Shares Outstanding | 86.67M |
| % Held by Institutions | 106.32 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
